Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: MS-2 Step TM
Active ingredients: mifepristone, misoprostol
What it is used for
MS-2 Step is indicated in females of childbearing age for the medical termination of a developing intrauterine pregnancy, up to 63 days of gestation.,It is recommended that the duration of pregnancy (i.e., up to 63 days gestation) be confirmed by ultrasound. In the event that an ultrasound is not possible, extra caution should be exercised.,Ultrasound is also useful to exclude ectopic pregnancy.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Tablet
White, flat round tablet with ml debossed on one side and 200 on the other side.
The way to take this medicine is: Buccal.
Part 2: Tablet
White to off-white, 11 mm diameter round biconvex tablet, with "MF" debossed on one side
The way to take this medicine is: Oral. This medicine is taken by mouth.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store below 25 degrees Celsius
- Protect from Light
- Store in Original Container
- Shelf lifetime is 24 Months.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November 1, 2021. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient misoprostol
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Metabolic syndrome - MyDr.com.au
Metabolic syndrome is a condition that increases your risk of heart disease, stroke and diabetes. Lifestyle changes are the first step in its treatment.
Read more on myDr website
Medical vs Surgical Abortion | Marie Stopes AU
Understanding the differences between surgical and medical abortion is an important step in making a decision that is right for your circumstances.
Read more on Marie Stopes Australia website
How to use Rhinocort - National Asthma Council Australia
Using your allergy nasal spray properly is important. This short video shows you how to use Rhinocort. Checklist of steps Blow nose gentlyShake nasa
Read more on National Asthma Council Australia website
Eyes wide shut: how caffeine can affect your sleep | Jean Hailes
It's often the first ritual in our day, but just how much caffeine is in that morning cup of coffee or tea
Read more on Jean Hailes for Women's Health website
About MumSpace - MumSpace
MumSpace is Australias new one-stop website supporting the mental health and emotional wellbeing of pregnant women, new mums and their families.
Read more on MumSpace website
How to use Autohaler - National Asthma Council Australia
Using your inhaler (puffer) properly is important when you have asthma or COPD (chronic obstructive pulmonary disease). This short video shows you how to use a
Read more on National Asthma Council Australia website
Talking to Your Children about Spinal Cord Injury: A Practical Guide for Families.
As social workers in the spinal cord injury (SCI) fi eld we acknowledge that there has been a gap in services, resources and support for parents and families to explain their injury to children. Parents engaged in NSW Spinal Services provided informal feedback regarding the lack of specifi c resources available to them to assist their child relatives through the impact of spinal cord injury on their family.
Read more on ACI - Agency for Clinical Innovation website
How to use Accuhaler - National Asthma Council Australia
Using your inhaler (puffer) properly is important when you have asthma or COPD (chronic obstructive pulmonary disease). This short video shows you how to use a
Read more on National Asthma Council Australia website
The hazards of rapid approval of new drugs | Issue 1 | Volume 39 | Australian Prescriber
The attempt to speed up drug registration approvals could be detrimental for the appropriateness and safety of new medicines in Australia.
Read more on Australian Prescriber website
Managing acute pulmonary oedema | Issue 2 | Volume 40 | Australian Prescriber | Australian Prescriber
In an area of limited clinical evidence, what are the first-line treatments for acute pulmonary oedema?
Read more on Australian Prescriber website
Top results
Social Phobia
Social phobia, the fear of being judged negatively, is often not recognised because patients do not like to talk about their fears. It is also not recognized because clinicians either confuse it with shyness, or judge the secondary depression or substance dependence to be the primary disorder.
Read more on CRUfAD – Clinical Research Unit for Anxiety and Depression website
Drug and Alcohol Withdrawal | Ausmed
In the context of withdrawal from drugs and alcohol, it is crucial that the concept of addiction and dependence is first acknowledged. Prolonged or excessive use of a substance can lead to tolerance and physical dependence. This process in itself is complex and depends on many factors.
Read more on Ausmed Education website
Transparency is good, independence from pharmaceutical industry is better! | Issue 4 | Volume 39 | Australian Prescriber
In Australia, the promotion of medicines to health professionals is controlled by self-regulatory schemes operated by the pharmaceutical industry.
Read more on Australian Prescriber website
The hazards of rapid approval of new drugs | Issue 1 | Volume 39 | Australian Prescriber
The attempt to speed up drug registration approvals could be detrimental for the appropriateness and safety of new medicines in Australia.
Read more on Australian Prescriber website
Improving transparency in the pharmaceutical industry | Issue 4 | Volume 39 | Australian Prescriber
Medicines Australia represents many of the companies that develop new prescription medicines. It believes that companies interactions with Australian...
Read more on Australian Prescriber website
Managing acute pulmonary oedema | Issue 2 | Volume 40 | Australian Prescriber | Australian Prescriber
In an area of limited clinical evidence, what are the first-line treatments for acute pulmonary oedema?
Read more on Australian Prescriber website
Switching and stopping antidepressants | Issue 3 | Volume 39 | Australian Prescriber
Switching people from one antidepressant to another is commonly needed but can cause drug withdrawal symptoms, drug interactions and relapse in depression....
Read more on Australian Prescriber website
Paediatric pharmacokinetics anddrug doses | Issue 6 | Volume 39 | Australian Prescriber
Find out practical advice for calculating drug doses in children.
Read more on Australian Prescriber website
Antihistamines and allergy | Australian Prescriber
There is now little role for sedating antihistamines in allergic conditions. Discover why they should be avoided.
Read more on Australian Prescriber website
Opioid prescribing pitfalls: medicolegal and regulatory issues | Issue 6 | Volume 38 | Australian Prescriber
Inappropriate opioid prescribing can lead to patient harm as well as a medicolegal risk to prescribers. Prescribers...
Read more on Australian Prescriber website
